Beijing Foyou Pharma CO.,LTD

SHSE:601089 주식 보고서

시가총액: CN¥7.5b

Beijing Foyou PharmaLTD 대차 대조표 상태

재무 상태 기준 확인 6/6

Beijing Foyou PharmaLTD has a total shareholder equity of CN¥3.5B and total debt of CN¥65.2M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥4.5B and CN¥1.1B respectively. Beijing Foyou PharmaLTD's EBIT is CN¥479.8M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥2.3B.

주요 정보

1.9%

부채 비율

CN¥65.23m

부채

이자 보상 비율-10.6x
현금CN¥2.30b
주식CN¥3.47b
총 부채CN¥1.07b
총 자산CN¥4.54b

최근 재무 상태 업데이트

Recent updates

Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Sep 29
Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

Apr 08
Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

재무 상태 분석

단기부채: 601089's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥1.0B).

장기 부채: 601089's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥50.4M).


부채 대 자본 내역 및 분석

부채 수준: 601089 has more cash than its total debt.

부채 감소: 601089's debt to equity ratio has reduced from 36.3% to 1.9% over the past 5 years.

부채 범위: 601089's debt is well covered by operating cash flow (968.6%).

이자 보장: 601089 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기